Lisinopril lowers blood pressure by blocking angiotensin II. This blocks aldosterone, which helps the body keep potassium and eliminate sodium and water (Hitner et al., 2022). This causes vasodilation, which lowers blood pressure. ACE inhibitors cause the exertion of sodium and water, which has an impact on electrolyte balance. Lab results may be abnormal as a result of this. In order to prevent hyperkalemia and hyponatremia, sodium and potassium electrolytes would be the ones to be monitored. Both drugs are used to treat heart failure and hypertension by lowering blood pressure. While there are disadvantages, the medication’s ability to lower blood pressure is one of the advantages. These medications lead to electrolyte imbalances, so lab work needs to be closely monitored. Since ARBs can also result in hypoglycemia, the patient must be aware of the need to monitor blood sugar levels. The liver and kidney functions are among the labs that are impacted by ARBs. Since spironolactone would worsen the electrolyte imbalance, it was discontinued. Potassium will increase more, and sodium will be even more depleted. These medications are potassium-sparing, meaning they don’t encourage the use of potassium.
Reply to this discussion post
